There are many notable initiatives in place by pharmaceutical companies to improve access to medicine around the world, especially in hard-to-reach and developing countries.

Gender parity in the workplace still has a long way to go, and the pharmaceutical industry is no exception, but many companies are taking significant strides in the right direction towards achieving this.

Over the past year investigation into cell therapies has grown markedly, with an estimated 80% increase; the US and China are taking the lead in the development of these therapies, with Europe the closest behind.

This infographic provides an overview of the new molecular entities/new active substances that were approved/recommended for approval by FDA and EMA in 2018.

There are a number of biologic medicines that have come off patent or are due to come off patent in the next few years. Learn more about the intricacies of the biologics market in this infographic.

In this infographic, we have displayed the events and stories that have had a big impact in the world of pharma in 2018. For this, we have focussed on three key areas: M&As, drug approvals, and appointments.

This infographic explores the top-performing drugs of 2017, and looks ahead to those that could triumph nearly a decade later. Find out which drugs are predicted to stay on top, and which others could be on their way down.

Find out about the latest movers and shakers in mergers and acquisitions, including how much money is being made and the pharmaceutical companies that are dominating the M&A space.